VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for CNS diseases and disorders for which current treatments fall short of patient needs, including depression and social anxiety disorder.
Contributions
Contributors
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
